Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Men are more likely to have larger basal cell carcinomas and squamous cell carcinomas, while women have more superficial basal cell carcinomas and tumors on their legs and central face.

Hirsutism is common body hair growth due to genetics and hormones, and while not a disease, it can be distressing; virilisation includes hirsutism with other male traits and needs medical attention.

The document advises health care providers on how to support transgender and gender-diverse youth with appropriate care and referrals.

Improved access to hair removal is crucial for transgender individuals before feminizing surgeries.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

Secondary aesthetic surgeries for gender reassignment are generally satisfying and advance overall aesthetic surgery techniques, but psychological support is important.

Hormonal treatments can change hair and skin in transgender people, but may not fully achieve desired results.

Transgender individuals can maintain stable kidney function post-transplant with gender-affirming care, but need careful management of hormone therapy risks and regular health screenings.

Testosterone therapy in transgender men has both desired effects like increased muscle mass and potential health risks such as higher cardiovascular risk.

Dermatologists should address discrimination and consider ethnic and gender differences in treatments.

The discovery of 5α-reductase deficiency in guevedoces led to the development of important urologic medications.

Understanding gender differences in COVID-19 is crucial for effective health strategies.

Hormone therapy in transgender people requires careful monitoring due to potential health risks and lack of standardized test values.

A new genetic change causing early stop in the androgen receptor gene was found in a patient with androgen insensitivity syndrome.

Dihydrotestosterone makes arteries stiffer in female mice by reducing estrogen receptor expression.

Accurate diagnosis and early specialist referral are crucial for managing 46,XY Disorders of Sex Development.

Gender-diverse people face more depression and anxiety, partly due to stress and lower cortisol levels.

Hormone treatment for transsexual individuals is effective but carries risks like thromboembolic events and mood changes, with most side effects being minor and reversible.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

Dermatologists should guide transgender patients on effective hair growth and loss treatments during hormone therapy.

Large language models often give biased or inaccurate medical responses, especially for LGBTQIA+ prompts.

Benign conditions can mimic serious ones in postmenopausal hyperandrogenism, requiring careful diagnosis.

Future hormone therapy trials should match the diverse needs and priorities of the gender-diverse community.

Goserelin injections can effectively manage hyperandrogenism symptoms in postmenopausal women who can't have surgery.

Male mice with FGF5 mutations grow longer hair than females.

Transgender men often get acne during transition, and treatment is similar to that for cisgender people, but pregnancy risks must be considered.

Transgender acne treatment requires a tailored approach with ongoing topical treatments and ceramide-rich moisturizers.

Mutations in the androgen receptor gene cause Androgen Insensitivity Syndrome, affecting sexual development.

Androgen receptors are active in many tissues of both male and female mice, not just reproductive organs.

GnRH-a or orchiectomy is more effective than anti-androgens for managing hormone levels in transgender women.